Exelixis is a leading oncology-focused biopharmaceutical company dedicated to the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. Driven by a passion for scientific innovation and patient-centered care, the company has built a robust portfolio of transformative therapies that are making a real difference in the lives of patients worldwide.
At Exelixis, employees are part of a mission-driven organization that values curiosity, collaboration, and high performance. The company fosters a professional culture where individuals are encouraged to grow, innovate, and contribute to meaningful medical breakthroughs in a supportive and inclusive environment.